The usefulness of carnitine medication in patients with decompensated liver cirrhosis

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2020
INTERVENTION: Intervention group: L‐carnitine 1500mg/day medication for 12 weeks. The dose increase and decrease is possible. non‐intervention group: non administration of L‐carinitine CONDITION: decompensated liver cirrhosis with carnitine deficiency PRIMARY OUTCOME: the improvement rate of Child‐Pugh score SECONDARY OUTCOME: the change of grasping power, serum ammonia, ; neuropsychological test,subjective symptom, increase or ; decrease medication, safety INCLUSION CRITERIA: The decompensated liver cirrhosis patients with Child‐Pugh score over 7 points, and satisfy the following criteria. 1. over 20 years old 2. written informed consent 3. can periodically go to hospital
Epistemonikos ID: 379344023f73429108e28a2d2888865858f135f1
First added on: Aug 24, 2024